Immediate osseointegrated implants for cancer patients: a review of clinical and cost-effectiveness
CADTH
            Record ID 32016000137
            English
                                                            
                Authors' recommendations:
                One study was included in this review. It was a retrospective controlled study which evaluated the effectiveness of immediate osseointegrated implants compared with delayed implants in patients with oral squamous cell carcinoma. The study provided very limited evidence that delayed and immediate osseointegrated implant protocols have similar implant survival rate at 5 years. However, there was no information about other outcomes of interest such as the impact of treatment on quality of life, oral function, and complications.
            
                                    
            Details
                        
                Project Status:
                Completed
            
                                                            
                Year Published:
                2015
            
                                    
                URL for published report:
                http://www.cadth.ca/sites/default/files/pdf/htis/jan-2015/RC0622_Immediate%20osteointergrated%20implants%20Final.pdf
            
                                                            
                English language abstract:
                An English language summary is available
            
                                    
                Publication Type:
                Rapid Review
            
                                    
                Country:
                Canada
            
                                                
                        MeSH Terms
            - Dental Implantation
- Head and Neck Neoplasms
- Jaw Neoplasms
- Mouth Neoplasms
- Osseointegration
Contact
                        
                Organisation Name:
                Canadian Agency for Drugs and Technologies in Health
            
            
                        
                Contact Address:
                600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
            
                                    
                Contact Name:
                requests@cadth.ca
            
                                    
                Contact Email:
                requests@cadth.ca
            
                                    
                Copyright:
                Canadian Agency for Drugs and Technologies in Health (CADTH)
            
                    
                This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.